Connect Biopharma Holdings Limited (CNTB) Social Stream



Connect Biopharma Holdings Limited (CNTB): $1.27

0.01 (-0.78%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add CNTB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#108 of 341

in industry

CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CONNECT BIOPHARMA HOLDINGS LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 3 $32 $27 $30 $1.18 2442.37%
2022-04-08 3 $25 $19 $22 $1.18 1764.41%
2022-05-04 3 $13 $1.5 $7.833 $1.18 563.81%
2022-06-06 4 $13 $1.5 $7.125 $1.18 503.81%
2022-09-15 4 $9 $1.75 $5.687 $1.18 381.95%
2023-02-08 2 $7 $1.75 $5.187 $1.18 339.58%
2023-04-12 3 $7 $1.75 $5.187 $1.18 339.58%
2023-07-11 2 $7 $5 $6.333 $1.18 436.69%
2023-09-13 2 $7 $5 $6 $1.18 408.47%
2023-12-12 1 $7 $7 $7 $1.18 493.22%

The Trend in the Analyst Price Target


CNTB's average price target has moved up $0.67 over the prior 154 days.

Over the past 44 weeks, CNTB's average upside potential has been 507.86%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 4 7 1.75 5.187 1.17 343.33%
2023-02-08 2 7 1.75 5.187 1.17 343.33%
2023-04-12 3 7 1.75 5.187 1.12 363.12%
2023-04-12 2 7 1.75 5.187 1.12 363.12%
2023-04-12 2 7 5.00 6.333 1.12 465.45%

CNTB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


CNTB's average broker recommendation rating improved by 0 over the prior 25 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNTB as an investment opportunity.

  • CNTB has a higher upside potential (average analyst target price relative to current price) than 1034.11% of all US stocks.
  • CONNECT BIOPHARMA HOLDINGS LTD's number of analysts covering the stock is higher than 78.09% of all US stocks.
  • CONNECT BIOPHARMA HOLDINGS LTD's average analyst price target is greater than 114.17% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, CONNECT BIOPHARMA HOLDINGS LTD's variance in analysts' estimates is lower than -479.96% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CONNECT BIOPHARMA HOLDINGS LTD are EWTX, RAIN, and VERA.

What is the outlook for CNTB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!